4 completed, 4 recruiting, 1 active not recruiting, 1 not yet recruiting. 10 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 4, Recruiting 4, Active not recruiting 1, Not yet recruiting 1 |
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow DEXA: new trials by email Literature Review of DEXA trials Research Report on DEXA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial Androgen Receptor Pathway Inhibitor, Transdermal Estrogen, Bone Scan - Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 60 | 2026-12-01 | 2026-11-02 |
| Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) Ruxolitinib, Etoposide, Dexamethasone - Hemophagocytic Lymphohistiocytoses | Phase 2 | Recruiting | Jerry Lee, MD, MSc, MPhil | 54 | 2024-10-01 | 2026-09-21 |
| Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study Biopsy Procedure, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Recruiting | University of Washington | 69 | 2024-05-21 | 2026-07-21 |
| Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer Biospecimen Collection, Bone Scan, Brachytherapy - Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 | Phase 2 | Not yet recruiting | University of Kansas Medical Center | 90 | 2023-11-20 | 2023-11-13 |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint - Colorectal Carcinoma, Endometrial Carcinoma | Phase 1 / Phase 2 | Recruiting | Children's Oncology Group | 147 | 2021-11-08 | 2026-08-25 |
| The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy. Dexamethasone 24mg Solution for Injection, Saline Solution for Injection - Dexamethasone, Hip Dysplasia | Phase 2 / Phase 3 | Completed | Odense University Hospital | 90 | 2020-11-12 | 2024-04-02 |
| Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation e-ATG, Immunosuppression Only Conditioning, Reduced Intensity Conditioning - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 71 | 2018-09-04 | 2026-03-17 |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Rituximab, Conditioning chemotherapy, TMS - Myelodysplastic Syndromes, Hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2015-09-24 | 2025-09-30 |
| Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma Pemetrexed, Cisplatin, Dexamethasone - Urothelial Carcinoma | Phase 2 | Completed | Asan Medical Center | 42 | 2008-07-01 | 2014-09-25 |
| Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients Perifosine, Bortezomib, Dexamethasone - Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1 / Phase 2 | Completed | AEterna Zentaris | 84 | 2006-08-01 | 2018-02-23 |
Prostatic Neoplasms (3) · Lymphoma, Non-Hodgkin (2) · Multiple Myeloma (2) · Agnosia (1) · Autoimmune Diseases (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Transitional Cell (1) · Colorectal Neoplasms (1) · Common Variable Immunodeficiency (1) · Desmoid Tumors (1) · Endometrial Neoplasms (1) · Hepatoblastoma (1) · Hip Dislocation (1) · Hodgkin Disease (1) · Immune System Diseases (1)
National Cancer Institute (NCI) (2) · AEterna Zentaris (1) · Asan Medical Center (1) · Children's Oncology Group (1) · Fred Hutchinson Cancer Center (1) · Jerry Lee, MD, MSc, MPhil (1) · Odense University Hospital (1) · University of Kansas Medical Center (1) · University of Washington (1)
United States (7) · Denmark (1) · South Korea (1)
Alain Mina, M.D. (1) · Dimana Dimitrova, M.D. (1) · Jerry Lee, MD (1) · Michael Schweizer (1) · Michael Schweizer, MD (1) · Paul Richardson, MD (1) · Sarah B Whittle (1) · Viktoria Lindberg-Larsen, MD, PhD (1) · Xinglei Shen (1)
PMID 21990396, PMID 25429526, PMID 40331908, PMID 40460271
2019 (1), P30CA168524 (1), P50CA097186 (1), UM1CA228823 (1)